Good Ventures awarded a grant of $300,000 to Yale University to support research on antibodies that change the permeability of the blood-brain barrier. If effective, the antibodies could enable new approaches toward treating Alzheimer’s disease, strokes, and other neurological disorders. This funding is intended to support work to identify the most effective antibodies, conduct affinity maturation of antibodies, and administer initial efficacy tests.
- Yale University
- Award Date:
- To support research on antibodies that change the permeability of the blood-brain barrier.